Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nephropathy, IGA”

283 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 283 results

Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Not applicableStudy completedNCT00006137
What this trial is testing

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

Who this might be right for
IGA Glomerulonephritis
National Center for Research Resources (NCRR) 43
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807995
What this trial is testing

Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Vertex Pharmaceuticals Incorporated 605
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Large-scale testing (Phase 3)Study completedNCT03643965
What this trial is testing

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 365
Not applicableLooking for participantsNCT01802034
What this trial is testing

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Who this might be right for
Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2 more
The Rogosin Institute 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06989359
What this trial is testing

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

Who this might be right for
IgANC3GComplement-mediated Kidney Disease+2 more
ADARx Pharmaceuticals, Inc. 45
Not applicableUnknownNCT05132621
What this trial is testing

The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.

Who this might be right for
Systemic Lupus ErythematosusImmunoglobulin A Nephropathy
Medical University of Warsaw 150
Large-scale testing (Phase 3)Looking for participantsNCT06963827
What this trial is testing

Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

Who this might be right for
Kidney Disease
Takeda 347
Large-scale testing (Phase 3)Active Not RecruitingNCT06564142
What this trial is testing

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex 605
Not applicableUnknownNCT03015974
What this trial is testing

Registry of IgA Nephropathy in Chinese Children

Who this might be right for
IgA NephropathyProteinuria in Nephrotic RangeImmunosuppressive Treatment
Peking University First Hospital 1,200
Not applicableStudy completedNCT01451710
What this trial is testing

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 30
Large-scale testing (Phase 3)Looking for participantsNCT05510323
What this trial is testing

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

Who this might be right for
Glomerulonephritis, IGA
Air Force Military Medical University, China 208
Testing effectiveness (Phase 2)Looking for participantsNCT06740526
What this trial is testing

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

Who this might be right for
IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05797610
What this trial is testing

Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Primary IgA Nephropathy
Hoffmann-La Roche 459
Post-approval studies (Phase 4)Study completedNCT01115426
What this trial is testing

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

Who this might be right for
IGA Glomerulonephritis
University Magna Graecia 20
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Very early researchEnrolling By InvitationNCT07135219
What this trial is testing

Cizutamig in Patients With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Peking University First Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00767221
What this trial is testing

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

Who this might be right for
IGA Nephropathy
Calliditas Therapeutics AB 20
Next Page